Why was sibutramine banned in Singapore for weight loss products?

Question

Accepted Answer

Sibutramine Was Banned in Singapore Due to Significant Health Risks

Sibutramine was banned in Singapore for use in weight loss products due to its association with an increased risk of serious cardiovascular events, specifically heart attack and strokes. The substance was previously available as a prescription-only medication for weight management. Beyond cardiovascular concerns, sibutramine has also been linked to other severe adverse effects, including insomnia, hallucinations, and auditory hallucinations.
Cardiovascular Risks Identified

The primary reason for the ban on sibutramine, implemented in Singapore in 2010, stemmed from its established link to heightened risks of heart attack and strokes. These findings necessitated its removal from the market to protect public health from these potentially life-threatening cardiovascular complications.
Associated Adverse Effects

In addition to the cardiovascular dangers, sibutramine consumption has been associated with a range of other serious health issues. These include significant sleep disturbances like insomnia, as well as psychological effects such as hallucinations and the experience of hearing voices, indicating potential neurological or psychiatric impacts.
Regulatory Action and Public Warning

The Health Sciences Authority (HSA) in Singapore has issued warnings regarding products found to contain sibutramine. This action is part of a broader effort to prevent the public from encountering harmful substances in consumer goods. The HSA's vigilance aims to safeguard individuals from the severe health consequences linked to the illicit presence of banned ingredients in weight loss products.

Reading history

Hide →

This history is cleared when the page is closed.

Why was sibutramine banned in Singapore for weight loss products?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends